| 注册
首页|期刊导航|中国癌症杂志|2025年美国癌症统计数据解读及对中国癌症防治工作的借鉴意义

2025年美国癌症统计数据解读及对中国癌症防治工作的借鉴意义

牟思博 周昌明 郑莹

中国癌症杂志2025,Vol.35Issue(6):523-530,8.
中国癌症杂志2025,Vol.35Issue(6):523-530,8.DOI:10.19401/j.cnki.1007-3639.2025.06.001

2025年美国癌症统计数据解读及对中国癌症防治工作的借鉴意义

Interpretation of US cancer statistics 2025 and its implications for cancer prevention and treatment in China

牟思博 1周昌明 2郑莹2

作者信息

  • 1. 复旦大学公共卫生学院,上海 200032||复旦大学附属肿瘤医院肿瘤预防部,复旦大学上海医学院肿瘤学系,上海 200032
  • 2. 复旦大学附属肿瘤医院肿瘤预防部,复旦大学上海医学院肿瘤学系,上海 200032||上海肿瘤疾病人工智能工程技术研究中心,上海 200032
  • 折叠

摘要

Abstract

In January 2025,American Cancer Society released the latest cancer statistics,projecting approximately 2 041 910 new cancer cases and 618 120 cancer-related deaths in the United States(U.S.).The cancer mortality rate in the U.S.continues to decline,with a reversal in gender disparities and an increasing cancer burden among middle-aged and young populations.Significant differences in incidence and mortality rates are attributed to variations in population characteristics,intervention screening measures,healthcare accessibility,and policy factors across different regions and populations within the U.S.Compared with the U.S.,the cancer spectrum in China is different,and the incidence rates of lung cancer and breast cancer are rapidly rising among young women,with an average annual growth rate exceeding 3%.Infection-related cancer incidence rates are relatively high,with the incidence of gastric cancer,liver cancer and cervix cancer in China being 25.4/105,26.0/105 and 21.8/105 in 2022 respectively,surpassing U.S.incidence levels.Alarmingly,the cumulative HPV vaccination coverage among eligible Chinese women during 2018-2020 was merely 2.24%,reflecting dual barriers of low screening compliance and inadequate prevention infrastructure.There is a need to further enhance primary cancer prevention and comprehensive risk factor control,prioritize cancer prevention strategies for young and female populations,formulate population-tailored prioritized prevention frameworks and strengthen multi-stakeholder financing mechanisms for personalized screening programs,with the aim of achieving the"Healthy China 2030"cancer prevention and control goals and contributing China's approach to global cancer governance.

关键词

癌症/流行病学/统计/癌症防控/公平性

Key words

Cancer/Epidemiology/Statistics/Cancer control/Equity

分类

医药卫生

引用本文复制引用

牟思博,周昌明,郑莹..2025年美国癌症统计数据解读及对中国癌症防治工作的借鉴意义[J].中国癌症杂志,2025,35(6):523-530,8.

基金项目

上海市2024年度"科技创新行动计划"科普专项(24DZ2300300) (24DZ2300300)

上海市公共卫生研究专项(2024GKM32) (2024GKM32)

上海市徐汇区院地合作项目(23XHYD-04) (23XHYD-04)

上海市加强公共卫生体系建设三年行动计划优青项目(GWVI-11.2-YQ37). Shanghai 2024 Science and Technology Innovation Action Plan(24DZ2300300) (GWVI-11.2-YQ37)

Shanghai Public Health Research Special Project(2024GKM32) (2024GKM32)

Xuhui District Institution-Local Cooperation Project(23XHYD-04) (23XHYD-04)

Three-year action plan for strengthening the construction of the public health system in Shanghai(GWVI-11.2-YQ37). (GWVI-11.2-YQ37)

中国癌症杂志

OA北大核心

1007-3639

访问量0
|
下载量0
段落导航相关论文